Roughly 30-44% of people experience nausea with Wegovy, while 40-45% report it with Zepbound
doi: 10.1001/jama.2023.3371 [PubMed] 37405349 Giordani AS, Baritussio A, Vicenzetto C, Peloso-Cattini MG, Pontara E, Bison E, Fraccaro C, Basso C, Iliceto S, Marcolongo R, Caforio ALP
GLP-1s are a class of medications initially developed to manage type 2 diabetes by improving glycemic control
Protocol Notes Injection burden: Separate vials may require up to 3 injections on TB-500 days and 2 on other days
doi: 10.1159/000534725, 28
J Neurol Neurosurg Psychiatry 47:564566 Article PubMed PubMed Central CAS Google Scholar Yilmaz E, Karakurt L, Serin E, Gzel H (2004) Peroneal nerve palsy due to rare reasons: a report of three cases